Literature DB >> 8655216

Treatment of systemic neonatal candidiasis with fluconazole.

H Bilgen, E Ozek, V Korten, B Ener, D Molbay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8655216     DOI： 10.1007/bf01713579

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  3 in total

1.  Fluconazole in neonatal disseminated candidiasis.

Authors:  D B Wiest; S L Fowler; S S Garner; D R Simons
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

Review 2.  Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.

Authors:  J E Edwards; S G Filler
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

Review 3.  Systemic fungal infections in neonates.

Authors:  P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747
  3 in total
  4 in total

Review 1.  Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.

Authors:  Kevin Watt; Paolo Manzoni; Michael Cohen-Wolkowiez; Stefano Rizzollo; Elena Boano; Evelyne Jacqz-Aigrain; Daniel K Benjamin
Journal:  Curr Drug Metab       Date:  2013-02       Impact factor: 3.731

Review 2.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.

Authors:  M A Pfaller; S A Messer; R J Hollis; L Boyken; S Tendolkar; J Kroeger; D J Diekema
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

Review 4.  Safety of fluconazole in paediatrics: a systematic review.

Authors:  Oluwaseun Egunsola; Abiodun Adefurin; Apostolos Fakis; Evelyne Jacqz-Aigrain; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2013-01-17       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.